Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center: The Comparison of Angioplasty and Pre-hospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) cost-efficacy sub-study

Journal of the American College of Cardiology

Volumn 45, Issue 4, 2005, Pages 515-524

  Machecourt, Jacques ^a   Bonnefoy, Eric ^b   Vanzetto, Gérald ^a   Motreff, Pascal ^c   Marlière, Stéphanie ^a   Leizorovicz, Alain ^d   Allenet, Benoit ^a   Lacroute, Jean Michel ^e   Cassagnes, Jean ^c   Touboul, Paul ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d Laennec Rockefeller University   (France)

^e Serv d'Aide Méd Urgente 38   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DATA ANALYSIS; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 13544259703     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.11.031     Document Type: Article

References (26)

1. T.J. Ryan, E.M. Antman, N.H. Brooks 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) Circulation 100 1999 1016 1030
2. M.E. Bertrand, M.L. Simoons, K.A. Fox Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 23 2002 1809 1840
3. The European Myocardial Infarction Project Group (EMIP) Pre hospital thrombolytic therapy in patients with suspected acute myocardial infarction N Engl J Med 329 1993 383 389
4. L.J. Morrison, P.R. Verbeek, A.C. McDonald Mortality and pre-hospital thrombolysis for acute myocardial infarction: a meta-analysis JAMA 283 2000 2686 2692
5. E.C. Keeley, J.A. Boura, C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
6. C.L. Grines, D.R. Westerhausen Jr, L.L. Grines Air PAMI Study Group A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study J Am Coll Cardiol 39 2002 1713 1719
7. P. Widimsky, T. Budesinsky, D. Vorac., for the 'PRAGUE' Study Group Investigators Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial PRAGUE-2 Eur Heart J 24 2003 94 104
8. H.R. Andersen, T.T. Nielsen, K. Rasmussen., for the DANAMI-2 Investigators A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742
9. E. Bonnefoy, F. Lapostolle, A. Leizorovicz Primary angioplasty versus pre hospital fibrinolysis in acute myocardial infarction: a randomised study Lancet 360 2002 825 829
10. M.J. De Boer, B.A. Van Hout, A.L. Liem A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction Am J Cardiol 76 1995 830 833
11. N.R. Every, L.S. Parsons, M. Hlatky., for the Myocardial Infarction Triage and Intervention (MITI) Investigators A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction N Engl J Med 335 1996 1253 1260
12. G.W. Stone, C.L. Grines, D. Rothbaum Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial J Am Coll Cardiol 29 1997 901 907
13. M.R. Le May, R.F. Davies, M. Labinaz Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: cost analysis of the Canadian STAT Study Circulation 108 2003 2624 2630
14. W.S. Weintraub, E.M. Mahoney, Z. Zhang One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial Heart 90 2004 782 788
15. D.B. Mark, J.D. Talley, E.J. Topol Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty EPIC Investigators Circulation 94 1996 629 635
16. A.M. Lincoff, D.B. Mark, J.E. Tcheng Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial Circulation 102 2000 2923 2929
17. E.M. Mahoney, C.T. Jurkovitz, H. Chu., for the TACTICS-TIMI 18 Investigators. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarctionJAMA 288 2002 1851 1858
18. C.L. Grines, K.F. Browne, J. Marco., for the Primary Angioplasty in Myocardial Infarction (PAMI) Study Group A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction N Engl J Med 328 1993 673 679
19. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes Angioplasty Sub Study Investigators A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction N Engl J Med 336 1997 1621 1628
20. P.G. Steg, E. Bonnefoy, S. Chabaud Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial Circulation 108 2003 2851 2856
21. L. Wallentin, P. Goldstein, P.W. Armstrong Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction Circulation 108 2003 135 142
22. B.K. Nallamothu, E.R. Bates Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 92 2003 824 826
23. D.J. Cohen, D.A. Taira, R. Berezin Cost-effectiveness of coronary stenting in acute myocardial infarction results from the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) trial Circulation 104 2001 3039 3045
24. D.A. Taira, T.B. Seto, R. Siegrist, R. Cosgrove, R. Berezin, D.J. Cohen Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials Am Heart J 145 2003 452 458
25. A. Gandjour, F. Kleinschmit, K.W. Lauterbach INTERCARE International Investigators European comparison of costs and quality in the treatment of acute myocardial infarction (2000-2001) Eur Heart J 23 2002 858 868
26. J. Machecourt, J. Dumoulin, J. Calop Cost effectiveness of thrombolytic treatment for myocardial infarction: comparison of anistreplase, alteplase and streptokinase in 270 patients treated within 4 hours Eur Heart J 14 1993 75 83